OCS logo

Oculis Holding AG (OCS) Company Overview

Profile

Full Name:

Oculis Holding AG

Sector:

Healthcare

Industry:

Biotechnology

Country:

Switzerland

IPO:

May 18, 2021

Indexes:

Not included

Website:

http://oculis.com

Description:

Oculis Holding AG is a biopharmaceutical company focused on developing innovative treatments for eye diseases. They use advanced drug delivery technologies to improve the effectiveness of therapies, aiming to enhance patient outcomes in conditions like glaucoma and retinal diseases. Their goal is to transform eye care with new solutions.

Key Details

Price

$19.63

Market Cap

$823.38 M(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

-

Annual EPS

-$3.31(-166.83% YoY)

PE Ratio

-

Annual ROE

-88.63%

Annual Debt To Equity

0.01

Beta

-0.01

Events Calendar

Earnings

Next earnings date:

Mar 10, 2025

Recent quarterly earnings:

Nov 7, 2024

Recent annual earnings:

Mar 18, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Jan 7, 25 Chardan Capital
Buy
Jan 6, 25 HC Wainwright & Co.
Buy
Nov 11, 24 HC Wainwright & Co.
Buy
Oct 23, 24 HC Wainwright & Co.
Buy
Aug 28, 24 HC Wainwright & Co.
Buy
Jun 11, 24 HC Wainwright & Co.
Buy
Jun 11, 24 Chardan Capital
Buy
Jun 11, 24 Baird
Outperform
Jun 11, 24 B of A Securities
Buy
May 30, 24 HC Wainwright & Co.
Buy

Screeners with OCS included

Growing Shares Outstanding
Best performing stocks last 3 months
Healthcare sector
All stocks
Biotechnology industry
Small cap stocks
Earnings next week
Stocks with low beta
Stocks above SMA 200
NASDAQ earnings calendar

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Current Price

$19.63
OCS price is $19.63

Price All-time High

$23.08
OCS price is currently -14.95% below its historical high of $23.08

Price Analysts Target

-
OCS price consensus analysts' forecast is unknown

Price Today Change

+0.26%
OCS price is up +0.26% today

Price YTD Change

+10.1%
OCS price is up +10.1% since January 1st

Price 3-Year Change

+101.54%
OCS price is up +101.54% over the past 3 years

Market cap

Market Cap

$823.38 M
OCS market capitalization is $823.38 million

Market Cap 3-Year Change

-
OCS market capitalization 3-year change is unknown

Market Cap All-time High

$968.09 M
OCS market capitalization is currently -14.95% below its historical high of $968.09 million

Market Cap Sector Rank

73.19%
OCS market capitalization is higher than 73.19% of companies in Healthcare sector

Technical

Beta

-0.01
OCS beta is -0.01

200-day SMA

$14.92
OCS price is currently +31.60% above its 200-day simple moving average

14-day RSI

33.32
OCS 14-day relative strength index is 33.32

30-day Relative Volume

0.45
OCS 30-day relative volume is 0.45

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Annual Revenue

-
OCS annual revenue value is unknown

Annual Revenue Analysts Estimate

$911.87 K
OCS annual revenue is currently equal to the consensus analysts' forecast

Annual Revenue 1-Year Change

-
OCS annual revenue 1-year change is unknown

Annual Revenue Sector Rank

-
OCS annual revenue is unknown

Profit

Annual Gross Profit

-
OCS annual gross profit value is unknown

Annual Gross Margin

-
OCS annual gross profit margin value is unknown

Annual Operating Profit

-$51.06 M
OCS annual operating income is -$51.06 million

Annual Operating Margin

-
OCS annual operating profit margin value is unknown

Annual Net Income

-$98.90 M
OCS annual net profit is -$98.90 million

Annual Net Margin

-
OCS annual net profit margin value is unknown

EPS

Annual EPS

-$3.31
OCS annual earnings per share is -$3.31

Annual EPS Analysts Estimate

-$1.78
OCS annual earnings per share is currently +86.27% higher than the consensus analysts' forecast

Annual EPS 1-Year Change

-166.83%
OCS annual earnings per share is down -166.83% year-on-year

Annual EPS Sector Rank

30.96%
OCS annual earnings per share is higher than 30.96% of companies in Healthcare sector

ROA & ROE

Annual ROA

-72.64%
OCS annual return on assets is -72.64%

Annual ROE

-88.63%
OCS annual return on equity is -88.63%

EBIT & EBITDA

Annual EBIT

-$97.31 M
OCS annual earnings before interest & taxes is -$97.31 million

Annual EBITDA

-$96.99 M
OCS annual EBITDA is -$96.99 million

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

-
OCS price to earnings ratio value is unknown

PE Ratio Sector Rank

-
OCS price to earnings ratio is unknown

PB Ratio

PB Ratio

7.27
OCS price to book ratio is 7.27

PB Ratio Sector Rank

88.05%
OCS price to book ratio is higher than 88.05% of companies in Healthcare sector

PS Ratio

PS Ratio

-
OCS price to sales ratio value is unknown

PS Ratio Sector Rank

-
OCS price to sales ratio is unknown

Enterprise value

Enterprise Value

$782.50 M
OCS enterprise value is $782.50 million

Enterprise Value Sector Rank

72.69%
OCS enterprise value is higher than 72.69% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-10.04
OCS EV/EBITDA is -10.04

EV/EBITDA Sector Rank

12.59%
OCS EV/EBITDA is higher than 12.59% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Annual Current Ratio

5.29
OCS annual current ratio is 5.29

Annual Quick Ratio

-
OCS annual quick ratio value is unknown

Leverage

Annual Debt To Equity

0.01
OCS annual debt to equity ratio is 0.01

Annual Interest Coverage Ratio

-66.45
OCS annual interest coverage ratio is -66.45

Risk & Stability

Piotroski F-Score

-
OCS piotroski f-score value is unknown

Altman Z-Score

-
OCS altman z-score value is unknown

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Annual Total Assets

$136.14 M
OCS annual total assets is $136.14 million

Annual Non Current Assets

$15.88 M
OCS annual long term assets is $15.88 million

Annual Current Assets

$120.26 M
OCS annual total current assets is $120.26 million

Annual Cash & Cash Equivalents

$45.63 M
OCS annual cash & cash equivalents is $45.63 million

Equity

Annual Book Value

$111.59 M
OCS annual book value is $111.59 million

Annual Working Capital

$97.54 M
OCS annual working capital is $97.54 million

Liabilities

Annual Total Liabilities

$24.56 M
OCS annual total liabilities is $24.56 million

Annual Total Long Term Liabilities

$1.83 M
OCS annual total long term liabilities is $1.83 million

Annual Current Liabilities

$22.73 M
OCS annual total current liabilities is $22.73 million

Annual Accounts Payable

$9.04 M
OCS annual accounts payable is $9.04 million

Debt

Annual Total Debt

$720.30 K
OCS annual total debt is $720.30 thousand

Annual Total Debt 1-Year Change

+5.49%
OCS annual total debt is up +5.49% year-on-year

Annual Long Term Debt

$513.10 K
OCS annual long term debt is $513.10 thousand

Annual Short Term Debt

$207.20 K
OCS annual short term debt is $207.20 thousand

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Total Expenses

$51.06 M
OCS annual total expenses is $51.06 million

Annual Operating Expenses

$51.06 M
OCS annual total operating expenses is $51.06 million

Annual Cost Of Goods Sold

-
OCS annual cost of goods sold value is unknown

Annual SGA

$16.40 M
OCS annual SGA is $16.40 million

Annual D&A

$319.60 K
OCS annual depreciation & amortization is $319.60 thousand

Annual Interest Expense

$1.46 M
OCS annual interest expense is $1.46 million

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Annual CFO

-$59.97 M
OCS annual cash flow from operations is -$59.97 million

Annual CFO 1-Year Change

-128.09%
OCS annual cash flow from operations is down -128.09% year-on-year

Annual CFI

-$60.37 M
OCS annual cash flow from investing activities is -$60.37 million

Annual CFI 1-Year Change

-1522.88%
OCS annual cash flow from investing activities is down -1522.88% year-on-year

Annual CFF

$144.41 M
OCS annual cash flow from financing activities is $144.41 million

Annual CFF 1-Year Change

+7935.32%
OCS annual cash flow from financing activities is up +7935.32% year-on-year

Free CashFlow

Annual FCF

-$60.02 M
OCS annual free cash flow is -$60.02 million

Annual FCF 1-Year Change

-99.99%
OCS annual free cash flow is down -99.99% year-on-year

CAPEX

Annual CAPEX

-
OCS annual capital expenditures value is unknown

Annual CAPEX 1-Year Change

-
OCS annual capital expenditures 1-year change is unknown

Institutional Ownership

Similar stocks

AVAH logo
Aveanna Healthcare Holdings (AVAH)
Beta Bionics (BBNX)
CDMO logo
Avid Bioservices (CDMO)
AVBP logo
ArriVent BioPharma (AVBP)
ORGO logo
Organogenesis Holdings (ORGO)
COGT logo
Cogent Biosciences (COGT)
EMBC logo
Embecta (EMBC)
CRON logo
Cronos (CRON)
PNTG logo
Pennant (PNTG)

FAQ

  • What is the ticker symbol for Oculis Holding AG?
  • Does Oculis Holding AG pay dividends?
  • What sector is Oculis Holding AG in?
  • What industry is Oculis Holding AG in?
  • What country is Oculis Holding AG based in?
  • When did Oculis Holding AG go public?
  • Is Oculis Holding AG in the S&P 500?
  • Is Oculis Holding AG in the NASDAQ 100?
  • Is Oculis Holding AG in the Dow Jones?
  • When was Oculis Holding AG's last earnings report?
  • When does Oculis Holding AG report earnings?

What is the ticker symbol for Oculis Holding AG?

The ticker symbol for Oculis Holding AG is NASDAQ:OCS

Does Oculis Holding AG pay dividends?

No, Oculis Holding AG does not pay dividends

What sector is Oculis Holding AG in?

Oculis Holding AG is in the Healthcare sector

What industry is Oculis Holding AG in?

Oculis Holding AG is in the Biotechnology industry

What country is Oculis Holding AG based in?

Oculis Holding AG is headquartered in Switzerland

When did Oculis Holding AG go public?

Oculis Holding AG's initial public offering (IPO) was on May 18, 2021

Is Oculis Holding AG in the S&P 500?

No, Oculis Holding AG is not included in the S&P 500 index

Is Oculis Holding AG in the NASDAQ 100?

No, Oculis Holding AG is not included in the NASDAQ 100 index

Is Oculis Holding AG in the Dow Jones?

No, Oculis Holding AG is not included in the Dow Jones index

When was Oculis Holding AG's last earnings report?

Oculis Holding AG's most recent earnings report was on Nov 7, 2024

When does Oculis Holding AG report earnings?

The next expected earnings date for Oculis Holding AG is Mar 10, 2025